Susquehanna International Group, LLP Medi Wound Ltd. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.35 - $9.8 $39,204 - $284,592	-29,040 Reduced 62.84%	17,175 $24,000
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.35 $22,745 - $40,189	-17,102 Reduced 27.01%	46,215 $85,000
Q1 2022 May 16, 2022	BUY	$1.86 - $3.24 $22,749 - $39,628	12,231 Added 23.94%	63,317 $126,000
Q4 2021 Feb 14, 2022	BUY	$2.2 - $4.01 $112,389 - $204,854	51,086 New	51,086 $121,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $683M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.